Cell Impact AB (publ) reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was SEK 5.81 million compared to SEK 19.95 million a year ago. Revenue was SEK 5.63 million compared to SEK 23.8 million a year ago.

Net loss was SEK 23.44 million compared to SEK 30.54 million a year ago. Basic loss per share from continuing operations was SEK 0.04 compared to SEK 0.4 a year ago. Diluted loss per share from continuing operations was SEK 0.04 compared to SEK 0.4 a year ago.